By Business/Source
Currency:USD
2026/Q1
Stock NameRevenueRatio
Immunotherapies106.68M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States257M64.25%
Europe131.42M32.85%
International11.6M2.90%